AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24814272 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous periorbital fat injections
Number of subjects: 70
Study 22553292 — intervention group
Group type: EXPERIMENTAL
Intervention: Gd-EOB-DTPA
Number of subjects: 15
Study 22553292 — intervention group
Group type: COMPARATOR
Intervention: Mn-DPDP
Number of subjects: 15
Study 19730254 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure (5 and 15 cm H2O)
Number of subjects: 16
Study 19730254 — intervention group
Group type: COMPARATOR
Intervention: Control patients under invasive ventilation
Number of subjects: 16
Study 19730254 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 16
Study 17088020 — intervention group
Group type: EXPERIMENTAL
Intervention: S-ketamine
Number of subjects: 20
Study 17088020 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 20
Study 17088020 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study 17088020 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin
Number of subjects: 20
Study 17088020 — intervention group
Group type: EXPERIMENTAL
Intervention: QST measures
Number of subjects: 20
Study 16323322 — intervention group
Group type: EXPERIMENTAL
Intervention: Step-wise intervention plan including nutritional counseling (+/‐ lactase and/or psyllium), calcium carbonate, and loperamide.
Number of subjects: 18
Study 12083630 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention group (VG); 15 min video
Number of subjects: 251
Study 12083630 — intervention group
Group type: COMPARATOR
Intervention: Non-video comparison group (NVG); no video
Number of subjects: 251
Study 9523538 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg-O-Meter
Number of subjects: 39
Study 7664861 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (80 micrograms)
Number of subjects: 15
Study 7664861 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (80 micrograms) and sodium cromoglycate (20 mg) combined
Number of subjects: 15
Study 7664861 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (20 mg)
Number of subjects: 15
Study 7664861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 2708725 — intervention group
Group type: EXPERIMENTAL
Intervention: L-tryptophan supplementation and dietary manipulation
Number of subjects: 0
Study 2708725 — intervention group
Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 0
Study 935836 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical training for 4-6 months
Number of subjects: 23
Study 935836 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets for 4-6 months (Control group)
Number of subjects: 23
Study 29863450 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based pelvic floor muscle exercise (PFME) program supplemented with three supervised physiotherapy sessions.
Number of subjects: 86
Study 29863450 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based PFME program supplemented with three supervised physiotherapy sessions.
Number of subjects: 86
Study 30898689 — intervention group
Group type: COMPARATOR
Intervention: Double-blind placebo-controlled food challenge
Number of subjects: 55
Study 30898689 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported food allergy
Number of subjects: 55
Study 30898689 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptoms of food allergy
Number of subjects: 55
Study 30898689 — intervention group
Group type: EXPERIMENTAL
Intervention: Causative foods
Number of subjects: 55
Study 28231371 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralipid 10%
Number of subjects: 31
Study 28231371 — intervention group
Group type: COMPARATOR
Intervention: ABD (1mg/kg/day in dextrose 5%)
Number of subjects: 31
Study 27155451 — intervention group
Group type: EXPERIMENTAL
Intervention: Competitive Memory Training (COMET)
Number of subjects: 47
Study 27155451 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR)
Number of subjects: 47
Study 27155451 — intervention group
Group type: COMPARATOR
Intervention: Eye Movement Desensitization and Reprocessing (EMDR) followed by Competitive Memory Training (COMET)
Number of subjects: 47
Study 27155451 — intervention group
Group type: COMPARATOR
Intervention: Competitive Memory Training (COMET) followed by Eye Movement Desensitization and Reprocessing (EMDR)
Number of subjects: 47
Study 27155451 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-esteem improvements
Number of subjects: 47
Study 24164087 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative nebulised budesonide
Number of subjects: 100
Study 24164087 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 100
Study 22998340 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-free, artificially sweetened beverage (250 ml per day)
Number of subjects: 641
Study 22998340 — intervention group
Group type: COMPARATOR
Intervention: Sugar-containing beverage (250 ml per day providing 104 kcal)
Number of subjects: 641
Study 22998340 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-free group
Number of subjects: 641
Study 22998340 — intervention group
Group type: COMPARATOR
Intervention: Sugar group
Number of subjects: 641
Study 22998340 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined measurements of 136 children who discontinued and 477 who completed the study
Number of subjects: 641
Study 20634176 — intervention group
Group type: EXPERIMENTAL
Intervention: Colesevelam (3.75 g/d)
Number of subjects: 216
Study 18250617 — intervention group
Group type: EXPERIMENTAL
Intervention: Ghrelin administration (1 microg/kg)
Number of subjects: 21
Study 16371523 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral Cutting Balloon (PCB)
Number of subjects: 340
Study 16371523 — intervention group
Group type: COMPARATOR
Intervention: Standard Percutaneous Transluminal Angioplasty (PTA)
Number of subjects: 340
Study 11871738 — intervention group
Group type: COMPARATOR
Intervention: Standard amino acid solution (Vintène) for 10 days (Control group)
Number of subjects: 13
Study 11871738 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized amino acid solution during the last 5 days (Experimental group)
Number of subjects: 13
Study 11871738 — intervention group
Group type: COMPARATOR
Intervention: Both groups received total parenteral nutrition for 10 days
Number of subjects: 13
Study 10502210 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 40 mg daily (E40)
Number of subjects: 45
Study 10502210 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 10 mg daily (E10)
Number of subjects: 45
Study 10502210 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 20 mg daily (E20)
Number of subjects: 45
Study 10502210 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 5 mg daily (E10)
Number of subjects: 45
Study 8524557 — intervention group
Group type: EXPERIMENTAL
Intervention: Group S using Summit ExciMed UV 200
Number of subjects: 20
Study 8524557 — intervention group
Group type: COMPARATOR
Intervention: Group V using VisX 20:20 excimer laser system
Number of subjects: 20
Study 8524557 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft lens fitting
Number of subjects: 20
Study 8524557 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat PRK
Number of subjects: 20
Study 1702476 — intervention group
Group type: EXPERIMENTAL
Intervention: Single fraction radiation treatment (8, 10, 12, 15Gy)
Number of subjects: 31
Study 1702476 — intervention group
Group type: COMPARATOR
Intervention: Multifraction dose schedule (5Gy x 4, 5Gy x 5, 5Gy x 6)
Number of subjects: 31
Study 7374197 — intervention group
Group type: COMPARATOR
Intervention: Standard flow delivered by a roller pump
Number of subjects: 10
Study 7374197 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile flow induced by a 'pulsatile assist device'
Number of subjects: 10
Study 31974063 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple supervised exercises (walking and rising from a chair, ∼20 minutes/day)
Number of subjects: 268
Study 31974063 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 268
Study 30909539 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV-biofeedback training
Number of subjects: 50
Study 30909539 — intervention group
Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 50
Study 28810721 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose sirolimus (SRL) with extended-release tacrolimus (ER-TAC)
Number of subjects: 158
Study 28810721 — intervention group
Group type: COMPARATOR
Intervention: Mycophenolate mofetil (MMF) with extended-release tacrolimus (ER-TAC)
Number of subjects: 158
Study 25391263 — intervention group
Group type: EXPERIMENTAL
Intervention: CRS followed by HIPEC and then systemic chemotherapy (Group A)
Number of subjects: 120
Study 25391263 — intervention group
Group type: COMPARATOR
Intervention: CRS only and systemic chemotherapy (Group B)
Number of subjects: 120
Study 25391263 — intervention group
Group type: EXPERIMENTAL
Intervention: HIPEC group
Number of subjects: 120
Study 25391263 — intervention group
Group type: COMPARATOR
Intervention: Non-HIPEC group
Number of subjects: 120
Study 23030695 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab plus best supportive care (BSC)
Number of subjects: 453
Study 23030695 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care (BSC) alone
Number of subjects: 453
Study 21768319 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother-child bed-sharing at ages 1 to 3 years
Number of subjects: 944
Study 19812865 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient dense drink
Number of subjects: 176
Study 19812865 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 176
Study 17079523 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 16
Study 17079523 — intervention group
Group type: COMPARATOR
Intervention: Sham manipulative treatment
Number of subjects: 16
Study 14643625 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week functional exercise programme (40-min sessions, twice a week)
Number of subjects: 26
Study 14643625 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week functional exercise programme
Number of subjects: 26
Study 14643625 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise programme)
Number of subjects: 26
Study 10502644 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstacles of different heights
Number of subjects: 15
Study 8596480 — intervention group
Group type: EXPERIMENTAL
Intervention: Palmitic acid diet
Number of subjects: 12
Study 8596480 — intervention group
Group type: COMPARATOR
Intervention: Stearic acid diet
Number of subjects: 12
Study 1790040 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster mailing intervention two weeks after screening
Number of subjects: 272
Study 1790040 — intervention group
Group type: COMPARATOR
Intervention: Control group (no booster mailing)
Number of subjects: 272
Study 7120377 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-instructional strategies
Number of subjects: 0
Study 7120377 — intervention group
Group type: EXPERIMENTAL
Intervention: External self-instructional condition
Number of subjects: 0
Study 7120377 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation training
Number of subjects: 0
Study 7120377 — intervention group
Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 0
Study 31092118 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional high intensity interval training (TRAD, n=10)
Number of subjects: 19
Study 31092118 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodized high intensity interval training (PER, n=9)
Number of subjects: 19
Study 31092118 — intervention group
Group type: COMPARATOR
Intervention: Traditional high intensity interval training (TRAD)
Number of subjects: 19
Study 31092118 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodized high intensity interval training (PER)
Number of subjects: 19
Study 27565045 — intervention group
Group type: EXPERIMENTAL
Intervention: Validated diagnostic prediction model for AHF using patient age, clinician pretest probability for AHF, and NT-proBNP as a continuous value.
Number of subjects: 197
Study 27565045 — intervention group
Group type: COMPARATOR
Intervention: Standard care (blinded arm).
Number of subjects: 197
Study 25223178 — intervention group
Group type: EXPERIMENTAL
Intervention: Guilu Erxian Glue Cataplasm (GEGC)
Number of subjects: 60
Study 25223178 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 21798674 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 137
Study 21798674 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study 20412426 — intervention group
Group type: EXPERIMENTAL
Intervention: Udenafil 100 mg
Number of subjects: 104
Study 20412426 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 18056819 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsyndromal depressive symptoms (SSD)
Number of subjects: 204
Study 18056819 — intervention group
Group type: COMPARATOR
Intervention: Minimal or no depressive symptoms (Control)
Number of subjects: 204
Study 16287350 — intervention group
Group type: EXPERIMENTAL
Intervention: Football equipment on indoor rubberized track
Number of subjects: 68
Study 16287350 — intervention group
Group type: EXPERIMENTAL
Intervention: Football equipment on outdoor natural-grass field
Number of subjects: 68
Study 16287350 — intervention group
Group type: COMPARATOR
Intervention: Minimal apparel on indoor rubberized track
Number of subjects: 68
Study 16287350 — intervention group
Group type: COMPARATOR
Intervention: Minimal apparel on outdoor natural-grass field
Number of subjects: 68
Study 16287350 — intervention group
Group type: EXPERIMENTAL
Intervention: Football equipment for backs
Number of subjects: 68
Study 16287350 — intervention group
Group type: EXPERIMENTAL
Intervention: Football equipment for linemen
Number of subjects: 68
Study 16287350 — intervention group
Group type: EXPERIMENTAL
Intervention: Running on grass for backs
Number of subjects: 68
Study 16287350 — intervention group
Group type: EXPERIMENTAL
Intervention: Running on grass for linemen
Number of subjects: 68
Study 12297166 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP>5mg/l
Number of subjects: 113
Study 12297166 — intervention group
Group type: COMPARATOR
Intervention: CRP<5mg/l
Number of subjects: 113
Study 10078671 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 50 microg
Number of subjects: 18
Study 10078671 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 6.25 to 50 microg
Number of subjects: 18
Study 10078671 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine (all doses)
Number of subjects: 18
Study 10078671 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine spinal anesthesia (control)
Number of subjects: 18
Study 7733038 — intervention group
Group type: EXPERIMENTAL
Intervention: High stearate (HS) diet: 2.4% energy as palmitic acid (16:0) and 7.3% energy as stearic acid (18:0)
Number of subjects: 10
Study 7733038 — intervention group
Group type: COMPARATOR
Intervention: Low stearate (LS) diet: 1.5% energy as stearic acid (18:0) and 7.3% energy as palmitic acid (16:0)
Number of subjects: 10
Study 2158140 — intervention group
Group type: EXPERIMENTAL
Intervention: CY 222 (15,000 U AXa IC) administered via subcutaneous injection once daily for 14 days
Number of subjects: 30
Study 2158140 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 30
Study 6280332 — intervention group
Group type: EXPERIMENTAL
Intervention: suloctidil (Sulocton, Continental Pharma)
Number of subjects: 31
Study 6280332 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 31
Study 31194707 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing
Number of subjects: 0
Study 31194707 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver hydrofiber dressing
Number of subjects: 0
Study 31194707 — intervention group
Group type: EXPERIMENTAL
Intervention: Paraffin gauze dressing
Number of subjects: 0
Study 31194707 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial biguanide foam dressing
Number of subjects: 0
Study 27632215 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone intravitreal implant (DEX implant) 0.7 mg every 5 months
Number of subjects: 363
Study 27632215 — intervention group
Group type: COMPARATOR
Intervention: Ranibizumab 0.5 mg administered as per European Summary of Product Characteristics
Number of subjects: 363
Study 27632215 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone intravitreal implant (DEX implant)
Number of subjects: 363
Study 27632215 — intervention group
Group type: COMPARATOR
Intervention: Ranibizumab
Number of subjects: 363
Study 27514246 — intervention group
Group type: EXPERIMENTAL
Intervention: Light exercise (yoga or similar)
Number of subjects: 620
Study 27514246 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exercise (aerobic conditioning)
Number of subjects: 620
Study 27514246 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous exercise (aerobic conditioning)
Number of subjects: 620
Study 27514246 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 620
Study 24333244 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar transurethral resection
Number of subjects: 147
Study 24333244 — intervention group
Group type: COMPARATOR
Intervention: Monopolar transurethral resection
Number of subjects: 147
Study 22293876 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg intravenously, twice daily for 5 days
Number of subjects: 25
Study 22293876 — intervention group
Group type: COMPARATOR
Intervention: Pantoprazole 40 mg intravenously, twice daily for 5 days
Number of subjects: 25
Study 19059324 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel fixed dose combination tablet containing 300mg zidovudine (AZT) and 160mg lamivudine (3TC)
Number of subjects: 18
Study 19059324 — intervention group
Group type: COMPARATOR
Intervention: Duovir tablet
Number of subjects: 18
Study 17660644 — intervention group
Group type: EXPERIMENTAL
Intervention: Compomer
Number of subjects: 60
Study 17660644 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-modified GIC
Number of subjects: 60
Study 17660644 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite resin
Number of subjects: 60
Study 17660644 — intervention group
Group type: COMPARATOR
Intervention: Control (Intact teeth)
Number of subjects: 60
Study 17868806 — intervention group
Group type: EXPERIMENTAL
Intervention: Ejection Fraction (EF) ≤ 30%
Number of subjects: 674
Study 17868806 — intervention group
Group type: EXPERIMENTAL
Intervention: Ejection Fraction (EF) > 30% with other risk factors
Number of subjects: 674
Study 15613293 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesh placed in a sublay position
Number of subjects: 54
Study 15613293 — intervention group
Group type: COMPARATOR
Intervention: Conventional stoma
Number of subjects: 54
Study 11105479 — intervention group
Group type: EXPERIMENTAL
Intervention: Witnesses' confidence ratings
Number of subjects: 144
Study 11105479 — intervention group
Group type: COMPARATOR
Intervention: Investigators' confidence ratings
Number of subjects: 144
Study 11105479 — intervention group
Group type: EXPERIMENTAL
Intervention: Witnessing conditions (good vs poor)
Number of subjects: 144
Study 11105479 — intervention group
Group type: COMPARATOR
Intervention: Investigators' discrimination ability
Number of subjects: 144
Study 8814372 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 Gy in two fractions (524 patients)
Number of subjects: 1048
Study 8814372 — intervention group
Group type: EXPERIMENTAL
Intervention: 39 Gy in 13 fractions (153 patients)
Number of subjects: 1048
Study 8814372 — intervention group
Group type: COMPARATOR
Intervention: Other regimens (371 patients)
Number of subjects: 1048
Study 1462992 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytodiagnostic urinalysis
Number of subjects: 77
Study 6204534 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfacetamide-polymyxin B
Number of subjects: 0
Study 6204534 — intervention group
Group type: COMPARATOR
Intervention: Polymyxin B-neomycin-gramicidin (Neosporin, control)
Number of subjects: 0
Study 6204534 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-polymyxin B
Number of subjects: 0
Study 31046806 — intervention group
Group type: EXPERIMENTAL
Intervention: No Touch (NT) saphenous vein graft harvesting
Number of subjects: 250
Study 31046806 — intervention group
Group type: COMPARATOR
Intervention: Conventional (CON) saphenous vein graft harvesting
Number of subjects: 250
Study 31046806 — intervention group
Group type: EXPERIMENTAL
Intervention: No Touch (NT) saphenous vein graft harvesting (aggregated data)
Number of subjects: 250
Study 29959799 — intervention group
Group type: EXPERIMENTAL
Intervention: Jintrolong® 0.01 mg/kg
Number of subjects: 64
Study 29959799 — intervention group
Group type: EXPERIMENTAL
Intervention: Jintrolong® 0.06 mg/kg
Number of subjects: 64
Study 29959799 — intervention group
Group type: EXPERIMENTAL
Intervention: Jintrolong® 0.2 mg/kg
Number of subjects: 64
Study 29959799 — intervention group
Group type: EXPERIMENTAL
Intervention: Jintrolong® 0.5 mg/kg
Number of subjects: 64
Study 29959799 — intervention group
Group type: EXPERIMENTAL
Intervention: Jintrolong® 0.8 mg/kg
Number of subjects: 64
Study 29959799 — intervention group
Group type: COMPARATOR
Intervention: Conventional rhGH 0.067 mg/kg
Number of subjects: 64
Study 29959799 — intervention group
Group type: EXPERIMENTAL
Intervention: Jintrolong® 0.1 mg/kg
Number of subjects: 64
Study 29959799 — intervention group
Group type: EXPERIMENTAL
Intervention: Jintrolong® 0.4 mg/kg
Number of subjects: 64
Study 26575983 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACWY-TT
Number of subjects: 0
Study 26575983 — intervention group
Group type: COMPARATOR
Intervention: MenC-CRM197 (control)
Number of subjects: 0
Study 26575983 — intervention group
Group type: COMPARATOR
Intervention: Men-PS (control)
Number of subjects: 0
Study 24168074 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal Management Training (GMT) - 21 hours
Number of subjects: 38
Study 24168074 — intervention group
Group type: COMPARATOR
Intervention: Wait-list condition (Control)
Number of subjects: 38
Study 22760383 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-incision technique with two suture anchors
Number of subjects: 91
Study 22760383 — intervention group
Group type: COMPARATOR
Intervention: Double-incision technique with transosseous drill holes
Number of subjects: 91
Study 19461031 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg per day
Number of subjects: 4731